1. Home
  2. PHVS vs OXM Comparison

PHVS vs OXM Comparison

Compare PHVS & OXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • OXM
  • Stock Information
  • Founded
  • PHVS 2015
  • OXM 1942
  • Country
  • PHVS Netherlands
  • OXM United States
  • Employees
  • PHVS N/A
  • OXM N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • OXM Apparel
  • Sector
  • PHVS Health Care
  • OXM Consumer Discretionary
  • Exchange
  • PHVS Nasdaq
  • OXM Nasdaq
  • Market Cap
  • PHVS 862.3M
  • OXM 958.1M
  • IPO Year
  • PHVS 2021
  • OXM N/A
  • Fundamental
  • Price
  • PHVS $16.91
  • OXM $55.22
  • Analyst Decision
  • PHVS Strong Buy
  • OXM Sell
  • Analyst Count
  • PHVS 5
  • OXM 3
  • Target Price
  • PHVS $41.60
  • OXM $77.00
  • AVG Volume (30 Days)
  • PHVS 50.2K
  • OXM 368.3K
  • Earning Date
  • PHVS 05-07-2025
  • OXM 03-27-2025
  • Dividend Yield
  • PHVS N/A
  • OXM 4.81%
  • EPS Growth
  • PHVS N/A
  • OXM N/A
  • EPS
  • PHVS N/A
  • OXM 0.95
  • Revenue
  • PHVS N/A
  • OXM $1,530,524,000.00
  • Revenue This Year
  • PHVS N/A
  • OXM N/A
  • Revenue Next Year
  • PHVS N/A
  • OXM $3.08
  • P/E Ratio
  • PHVS N/A
  • OXM $59.97
  • Revenue Growth
  • PHVS N/A
  • OXM N/A
  • 52 Week Low
  • PHVS $14.14
  • OXM $54.58
  • 52 Week High
  • PHVS $26.57
  • OXM $113.88
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 55.23
  • OXM 22.50
  • Support Level
  • PHVS $14.49
  • OXM $57.55
  • Resistance Level
  • PHVS $17.00
  • OXM $64.55
  • Average True Range (ATR)
  • PHVS 1.32
  • OXM 2.63
  • MACD
  • PHVS 0.18
  • OXM -0.35
  • Stochastic Oscillator
  • PHVS 71.95
  • OXM 3.58

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

About OXM Oxford Industries Inc.

Oxford Industries Inc is an apparel manufacturing company that designs, sources, markets, and distributes products under the brand name Tommy Bahama, and Lilly Pulitzer. Tommy Bahama designs, sources, markets, and distributes men's and women's sportswear and related products. Lilly Pulitzer designs, sources, markets, and distributes upscale collections of women's and women's dresses, sportswear, and related products. The company generates a majority of its revenue from the Tommy Bahama division.

Share on Social Networks: